Search

Author/Creator Copeland, Amanda

1. A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma. (25th April 2017)

Authors:
Batlevi, Connie L.; Crump, Michael; Andreadis, Charalambos; Rizzieri, David; Assouline, Sarit E.; Fox, Susan; van der Jagt, Richard H. C.; Copeland, Amanda; Potvin, Diane; Chao, Richard; Younes, Anas
Journal:
British journal of haematology
Issue:
Volume 178:Number 3(2017)
Page Start:
434
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T‐cell lymphoma. (17th April 2013)

Authors:
Oki, Yasuhiro; Younes, Anas; Copeland, Amanda; Hagemeister, Fredrick; Fayad, Luis E.; McLaughlin, Peter; Shah, Jatin; Fowler, Nathan; Romaguera, Jorge; Kwak, Larry W.; Pro, Barbara
Journal:
British journal of haematology
Issue:
Volume 162:Number 1(2013:Jul.)
Page Start:
138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma. (27th July 2015)

Authors:
Oki, Yasuhiro; Fanale, Michelle; Romaguera, Jorge; Fayad, Luis; Fowler, Nathan; Copeland, Amanda; Samaniego, Felipe; Kwak, Larry W.; Neelapu, Sattva; Wang, Michael; Feng, Lei; Younes, Anas
Journal:
British journal of haematology
Issue:
Volume 171:Number 4(2015:Nov.)
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗